Qymune

San Francisco, United States

Qum Therapeutics Develops immunotherapies that target pathogenic cells and engage the patient’s immune system to control disease.

$10.0M raised

Nov 2025

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Qymune raised?

Qymune has raised $10.0M in total funding. The most recent round was Seed. The last funding was announced in November 2025.

Who are Qymune's investors?

Qymune's investors include Sazze Partners, Nextrans, Primer, Mirae Asset Capital, Aju IB Investment.

Where is Qymune headquartered?

Qymune is headquartered in San Francisco, United States.

What does Qymune do?

Qum Therapeutics Develops immunotherapies that target pathogenic cells and engage the patient’s immune system to control disease.

What stage is Qymune at?

Qymune is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 30, 2025.

MLA

"Qymune — Funding & Investors." VCBacked, November 30, 2025, https://www.vcbacked.co/company/qymune. Accessed July 2, 2026.

APA

VCBacked. (2025). Qymune — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/qymune

Wikipedia (cite web)

{{cite web |title=Qymune — Funding & Investors |url=https://www.vcbacked.co/company/qymune |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 30, 2025.